·
Receives the donors for blood donation
with a warm welcome and act as a bridge between the hospital staff and the
technical staff of the blood bank.
·
Well-trained staff does donor
screening, while Donor privacy and confidentiality is maintained at all times.
·
Pretest counselling to defer high-risk
donors is undertaken.
·
Blood bags with pre storage
leukoreduction filter are used that provide 3-4 logLeukoreduced blood. The
advantages of leucoreduction include:
1.
Prevention of Febrile Non Hemolytic
Transfusion Reactions (FNHTR)
2.
Prevention of HLA allo-immunization
3.
Reduction in transmission of
lymphotropic viruses such as EBV, CMV and HTLV-I & II.
4.
Prevention of immunomodulation
·
The bags also contain a sample pouch,
which diverts first 15-30 ml of blood that is used for testing. This has
significantly reduced bacterial contamination of blood products.
·
The sterile connecting device has made
it possible for us to provide blood components in parts for fulfilling
pediatric transfusion requirements. The various components prepared in our
BLOOD COMPONENT PREPARATION LABORATORY include:
1.
Leukoreduced Packed Red Cells (3-4 log
leukoreduction)
2.
Random Donor Platelets and Fresh Frozen
Plasma
3.
Cryoprecipitate
4.
AHG poor plasma
5.
Washed RBCs
6.
Irradiated RBCs
·
The IMMUNOHAEMATOLOGY LABORATORY is
a reference centre providing advanced Immunohaematology work-ups, not only for
in-house patients but also to patients from other hospitals.
·
Tests performed at our laboratory
include:
1.
Donor: Blood grouping (ABO & Rh),
Rh phenotyping and Immune antibody screening
2.
Patients: Grouping, antibody screening,
antibody identification and extended antigen typing if required.
3.
Cross matching
4.
Advanced work up such as
auto/alloadsorption& elution for solving of difficult cases.
5.
Direct & Indirect Antiglobulin
tests
6.
Coombs titre
·
The INFECTIOUS MARKER LABORATORY,
besides the five mandatory tests also performs testing of hepatitis B core
antibody on all the donated blood units and the units that are found positive
are discarded.
·
NUCLEIC ACID TESTING (NAT) LABORATORY: Individual Donor (ID)-NAT testing based on Transcription Mediated
Amplification by ProcleixUltrio Assay is done on all the donated blood units.
This has reduced the window period of HIV-I, HBV & HCV considerably and is
a step forward in our quest for zero risk blood.
·
APHERESIS AND OTHER SPECIAL PROCEDURES:
1. THE
APHERESIS LABORATORY is functional 24 hours, all days.
It is equipped with fully automated cell separators, which are flexible to
produce various components.
2.
The various procedures undertaken
include:
3.
Plateletpheresis
4.
Plasmapheresis
5.
Granulocytapheresis
·
Besides these the department also
performs special procedures such as:
1.
Therapeutic Plasma Exchange
2.
Peripheral Blood Stem Cell (PBSC)
collection: Autologous and Allogenic
3.
Red Cell Exchange
·
Voluntary blood donation program
The Department has initiated an in-house voluntary blood donation program
wherein a list of hospital employees willing to donate voluntarily is
maintained. This also includes donors with rare blood groups who can be called
at the Eleventh hour for blood donation. These Voluntary Blood Donors play a
pivotal role in maintaining safe and adequate blood supply that forms the
backbone of any Blood Transfusion Service.
The Department also maintains the registration of Voluntary Blood Donors who
are willing to donate blood at the IAH. These Voluntary Blood Donors are
encouraged to become regular repeat remunerated Voluntary blood donors instead
of just one-time voluntary blood donors. Voluntary donors at our hospital are
also provided with certain special incentives. As per the departmental policy
that all donors who have donated 4 times in a year or at least in 2 years are
entitled for an Executive Apollo Health Check-up. This is to ensure that our
voluntary donors remain in good health at all times.
·
Thalassemia initiative
The Department of Transfusion Medicine at Indraprastha Apollo Hospitals, New
Delhi is catering to the transfusion needs of approximately 75 Thalassemic
patients. We are providing NAT tested, 3 to 4 logleukoreduced blood for these
patients.
In addition we perform regular screening for any irregular red cell antibodies
and the extended blood group phenotyping of these patients, helping us in
providing the safest possible blood for them.
·
Molecular biology and transplant
immunology
During the past decade the pace of
discovery, invention and innovation in Genetics has accelerated dramatically,
more so in the Molecular Genetics arena.
The Apollo Group, in line with its commitment of providing world class services
second to none, not only has a cutting edge technology in the Genetic services
but also has an equally highly committed human resource comprising of skilled
doctors and Scientists to man these services.
Molecular Diagnostics has increased our understanding of oncology and we are no
longer treating cancer patients empirically but are able to assist the
oncologist in prognosis as well as finding Minimal Residual Disease. Today
Molecular diagnostics has reached a stage where it also plays a significant
role in investigating recurrent abortions, genetic anomalies and HLA tissue
typing for Organ transplantation, both solid organ and Bone Marrow transplants.
·
Services provided by immunology &
molecular biology
·
Prenatal & Postnatal Diagnosis
·
Chromosomal Analysis (GTG Banding) -
Abortus Material (Product of Conception)
·
Amniotic Fluid -FISH Ploidy for
Chromosome 21,18,13,X and Y (5 probes analysis)
·
Amniotic Fluid -Karyotyping-GTG banding
·
CVS cell culture for routine
karyotyping
·
CVS-Complete Chromosomal Analysis
(Karyotyping GTG Banding+ Ploidy analysis for Chromosome 21,18,13,X and Y by
FISH
·
CVS-FISH Ploidy for Chromosome
21,18,13,X and Y (5 probes analysis)
·
Cytogenetics
·
Stress Cytogenetics for Aplastic
Anaemia
·
Chromosomal Analysis (GTG Banding)
-Peripheral Blood
·
Chromosomal Analysis (GTG Banding)
-Bone Marrow
·
Couple Karyotype from peripheral blood
samples
·
Fluorescence in situ Hybridization
(FiSH) for Hematological malignancies
·
FISH FOR 1q25,LSI19q13/LSI19p13
·
Her 2 Neu Gene Amplification by FISH
with on Paraffin Embedded tissue Sections
·
FISH FOR CEP XY (MRD ASSESSMENT) for
Bone marrow transplant assessment
·
AML FISH panel
·
FISH FOR ALL PANEL (ANY 3 FISH PROBES)
TEL/AML, MLL, t(9;22), INV 16
·
FISH for CLL panel
·
FISH for AML panel
·
FISH FOR CEP-12
·
AML1/ETO t(8;21) translocation (FISH)
·
FISH FOR CML patients LSI BCR/ABL
t(9;22) f
·
N-myc FISH for neuroblastoma
·
FISH FOR LSI D7S486(7q31)CEP-7q LSI
1p36/LSI
·
FISH for MDS PANEL del(5q), del (7q)
·
FISH FOR MULTIPLE MYLEMOMA t(11;14),
t(14;18), 13q(del), p53(17p13)
·
HLA typing for Kidney, Liver and Bone
Marrow Transplant
·
HLA CLASS -I A,B,C / PCR-SSP/SSOP
·
HLA CLASS-II DQ/DR/PCR-SSP/SSOP
·
HLA LYMPHOCYTE CROSSMATCH&HLA
TYPING(DONOR&PATIENT)
·
HLA LYMPOCYTE CROSS MATCH NIH METHODS
·
BONE MARROW TRANSPLANT HLA TYPING
·
HLA B-27, HLA B-51, HLA B-17, HLA-B 15
(SSP- PCR)
·
PANEL REACTIVE ANTIBODY TEST
·
DONOR SPECIFIC ANTIBODY TEST
·
Infectious Marker Screening
·
HBV- Quantification(PCR)
·
HBV-Qualitative(PCR)
·
HCV-Quantitative(PCR)
·
HCV- Qualitative(PCR)
·
HCV genotype
·
HIV-Viral Load
·
MRD ASSESSMENT (Q-RT-PCR FOR BCR-ABL
GENE)
·
HIV Proviral DNA
·
HIV Genotypic Drug Resistance
·
Molecular Genetics
·
BETA Thallasemia - 5 COMMON MUTATIONS -
CHILD & PARENTS
·
THAL - MUTATIONS + XMN POLYMORPHISM
·
THALASSEMIA - (8) UNCOMMON MUTATIONS
·
THALASSEMIA - 2nd PRENATAL DIAGNOSIS
·
THALASSEMIA - ALPHA - DELETIONS (3.7
& 4.2 KB)
·
THALASSEMIA - ALPHA,BETA & GAMMA
GENE ANALYSIS
·
THALASSEMIA - PRENATAL DIAGNOSIS
·
THROMBOPHILIA PROFILE(FAC
V+MTHFR+PROTHROMBIM GENE)